There are significant differences in the biology of males and females, ranging from biochemical pathways 14 to behavioural responses, which are relevant to modern medicine. Broad-sense heritability estimates differ 15 between the sexes for many common medical disorders, indicating that genetic architecture can be sex-16 dependent. Recent genome-wide association studies (GWAS) have successfully identified sex-specific 17 and sex-biased effects, where in addition to sex-specific effects on gene expression, twenty-two medical 18 traits have sex-specific or sex-biased loci. Sex-specific genetic architecture of complex traits is also 19 extensively documented in model organisms using genome-wide linkage or association mapping, and in 20 gene disruption studies. The evolutionary origins of sex-specific genetic architecture and sexual 21 dimorphism lie in the fact that males and females share most of their genetic variation yet experience 22 different selection pressures. At the extreme is sexual antagonism, where selection on an allele acts in 23 opposite directions between the sexes. Sexual antagonism has been repeatedly identified via a number of 24 experimental methods in a range of different taxa. Although the molecular basis remains to be identified, 25 mathematical models predict the maintenance of deleterious variants that experience selection in a sex-26 dependent manner. There are multiple mechanisms by which sexual antagonism and alleles under sex-27 differential selection could contribute toward the genetics of common, complex disorders. The evidence 28
4 causes weight loss in males but decreased bone density in females [31] , and p53 over-expression in D. 121 melanogaster increases male life-span but reduces that of females [32] . Furthermore, a screen of 1,332 D. 122 melanogaster P-element insertion lines identified forty-one mutations that had sexually dimorphic effects 123 on life-span including six that were in opposite directions [33] . Although gene disruption studies do not 124 precisely reproduce the effect of natural genetic variation, they demonstrate that different pathways can 125 control the same trait. The question then is: how does this sexual dimorphism in genetic effects arise?
126
Insights from evolutionary biology are of great value here, since theory about the origin and evolution of 127 sex differences is well-developed, both on the phenotypic and on the genetic level. . This means that the fitness effect of a given height-determining allele will be 174 context-dependent in terms of sex, and that the population as a whole will be unlikely to evolve towards a 175 shorter phenotype, despite directional selection in females, because of counter-selection in males. One of 176 the major evolutionary implications of sexual antagonism is the maintenance of genetic variation that is 177 deleterious to one sex. Although this has not been fully demonstrated at the molecular level, the 
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Sexual dimorphism then evolves, causing the sexes to come closer to their respective phenotypic optima, 236 but some antagonism remains. D. Finally, the sexes achieve their optima and the antagonism is completely 237 resolved. Redrawn after information presented in [16] .
How sex-specific selection affects disease architecture

240
One implication of sexual antagonism is the maintenance of deleterious genetic variation at higher 241 population frequency than would be expected from mutation-selection balance [43, 44] . This leads us to 242 consider its role in susceptibility to common, genetically complex disorders. Consistent with this 243 reasoning, mathematical simulation predicts that alleles that are under sex-differential selection (including 244 sexually antagonistic ones) contribute disproportionately to genetic variation underlying disease 245 phenotypes [14] . We now discuss in greater depth how sexual antagonism for standing genetic variation 
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Sex-specific migration 273
It has been suggested that the genetic variation for a sexually antagonistic trait may vary between 274 populations [44], and thus immigration results in the introduction of novel, sexually antagonistic alleles 275 into the host population. Sex-biased immigration will cause alleles that are beneficial to that sex (and thus 276 under net positive selection) to be rapidly introduced into a host population, only for the opposite sex to 277 inherit novel deleterious alleles.
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The same principle could be applied to resolved antagonism. For example, methylation is both 279 sex-specific [65,66] and population-specific [67] . It is also proposed as a means by which sexual 280 antagonism can be resolved because it prevents a deleterious allele from being expressed in one sex. The 281 sex-specific migration results in novel combinations of methylated genes increasing the prevalence of 282 extreme (deleterious) phenotypes.
283
Although obtaining empirical evidence for these processes may be challenging, there is good For SNP-based association testing, the basic approach to identifying sex-specific effects is to analyse each 301 sex separately, i.e. sex-stratified. In comparison to joint tests, this approach is limited due to the loss in 302 power caused by partitioning of the sample [78]. A common follow-up to the sex-stratified tests is to 303 determine whether the association statistics for each sex are significantly different from one another.
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Many main-effect studies incorporate sex as a covariate into the analysis, i.e. they are controlling for the 305 effect. However, whilst this approach acknowledges sex-effects it doesn't allow for their detection. For 306 binary traits with a prevalence of less than 1% inclusion of known covariates actually reduces power [79].
307
A joint analysis that incorporates a genotype-by-sex interaction term tests the difference in 308 allele frequencies between male and female cases, given their allele frequencies in controls. It is thus more 309 suited to identifying genetic differences in trait architecture between males and females rather than for 
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Other covariates, such as those used to correct for population stratification, can also be incorporated into 
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The statistical behaviour of genotype-by-sex tests must be assumed to be similar to genotype- 
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As more sex-specific analyses of GWAS datasets are performed, it would be informative for 
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Despite sharing genetic variation, there are profound biological differences between males and females.
341
This can result in different optima for shared traits, sexual antagonism, and sexual dimorphism. Sex-342 specific selection on an allele can have important effects on its maintenance within a population, 343 potentially allowing deleterious, disease-associated alleles to persist [14, 43, 44] . This predicts the existence 344 of sex-specific architecture, and indeed the recent analyses of large GWAS data sets has brought about an 345 unprecedented rise in the number of robust sex-specific effects in traits of medical relevance (thirty-four 346 loci for twenty-two traits). In fact, we are aware of only one 'sex-sensitive' GWAS that did not reach 347 genome-wide significance [83]. Sex differences in disease presentation are often stated as the reason for 348 investigating sex-specific genetic effects, but given that sexual dimorphism is a resolution of sexual 349 antagonism, sexually monomorphic traits are more likely to harbour unresolved conflict and thus also 350 have sex-specific genetic architecture.
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Although we have partially excluded sex hormones from sex differences in genetic architecture, 
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We anticipate that analysis of GWAS data with respect to sex, encouraged by both evolutionary 373 genetics and recent results presented in this review, will generate many more significant findings and 374 highlight the potential role of sex-specific and sexually antagonistic selection as a potent force in human 375 genetic architecture. Finally, we hope that the identification of sex-specific genetic aetiologies in what 376 otherwise appears to be the same disease will result in the development of more effective, sex-specific 377 therapies. 
